Scholarlink

Introduction <p>Renal cell carcinoma (RCC) is an aggressive tumour originating from renal tubular epithelium, commonly metastasizing to the lungs, bones, liver, brain, and lymph nodes. Metastasis to the head and neck occurs in only about 15% of cases, and it is even rarer for a head and neck lesion to be the initial manifestation of RCC.</p> Methods <p>We conducted a 12-year case series of patients presenting to otolaryngology clinics with head and neck manifestations of metastatic RCC. Primary renal tumors were identified on ultrasound and confirmed histologically, and cases lacking imaging or histologic confirmation were excluded. Descriptive analyses were performed using Microsoft Excel (Version 16.85).</p> Results <p>Of 41 patients with metastatic head and neck lesions, 15 (36.6%) had a confirmed renal primary on imaging and biopsy and were included. The cohort showed a male predominance with a median age of 55 years. The nasal cavity was the most common site, typically presenting with epistaxis, followed by the scalp. All tumors showed clear cell morphology with positivity for Cytokeratin Cam 5.2, Pax8, and RCC, and negativity for CK7 and CK20. Most patients had no distant metastases, with fewer than one-quarter demonstrating brain involvement. Over half received chemotherapy or radiotherapy, and about one-quarter underwent nephrectomy.</p> Conclusion <p>Metastatic RCC should always be considered in the differential diagnosis of rapidly growing, hypervascular lesionsin the head and neck region, including skull base masses, particularly in men in their 50–70s, who represent a high-risk demographic.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Metastasis of renal cell carcinoma to the head and neck as first manifestation of disease: a case series

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月20日

查看全文
  • Syeda Maria Ahmad Zaidi,
  • Syed Roohan Aamir,
  • Hania Fatima,
  • Faiqa Binte Amir,
  • Maidha Ehsan,
  • Nasir Ud Din

摘要

Introduction

Renal cell carcinoma (RCC) is an aggressive tumour originating from renal tubular epithelium, commonly metastasizing to the lungs, bones, liver, brain, and lymph nodes. Metastasis to the head and neck occurs in only about 15% of cases, and it is even rarer for a head and neck lesion to be the initial manifestation of RCC.

Methods

We conducted a 12-year case series of patients presenting to otolaryngology clinics with head and neck manifestations of metastatic RCC. Primary renal tumors were identified on ultrasound and confirmed histologically, and cases lacking imaging or histologic confirmation were excluded. Descriptive analyses were performed using Microsoft Excel (Version 16.85).

Results

Of 41 patients with metastatic head and neck lesions, 15 (36.6%) had a confirmed renal primary on imaging and biopsy and were included. The cohort showed a male predominance with a median age of 55 years. The nasal cavity was the most common site, typically presenting with epistaxis, followed by the scalp. All tumors showed clear cell morphology with positivity for Cytokeratin Cam 5.2, Pax8, and RCC, and negativity for CK7 and CK20. Most patients had no distant metastases, with fewer than one-quarter demonstrating brain involvement. Over half received chemotherapy or radiotherapy, and about one-quarter underwent nephrectomy.

Conclusion

Metastatic RCC should always be considered in the differential diagnosis of rapidly growing, hypervascular lesionsin the head and neck region, including skull base masses, particularly in men in their 50–70s, who represent a high-risk demographic.